Found 15 matching trials
Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT N/A This multicenter retrospective study evaluated consecutive patients with la...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT PHASE4 Hepatocellular carcinoma (HCC) is the fourth most common cancer in China, w...
Show More Location
Beijing Ditan Hospital, Capital Medical University
Learn More & Join Trial
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT PHASE2 This study is conducted to evaluate the efficacy and safety of lenvatinib p...
Show More Location
The Second Affiliated Hospital of Guangzhou Medical University
Learn More & Join Trial
Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTT NA This is a multicentri prospective cohort study to investigate the safety an...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma PHASE2 Purpose: This phase II clinical trial evaluates whether a combination of li...
Show More Location
Multiple Locations
Learn More & Join Trial
TACE With Lenvatinib Versus Lenvatinib Alone in in First-line Treatment of Advanced HCC PHASE3 This trial is is an open label, multicenter, randomized controlled phase 3 ...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Combined DEB-TACE, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma PHASE2 This is an open-label, single-arm, phase 2 study. The purpose of study is t...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data N/A The system assesses the heterogeneity of HCC patients in terms of therapeut...
Show More Location
The Second Affiliated Hospital of Hainan Medical Universsity
Learn More & Join Trial
ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC PHASE2 This trial is designed to explore the efficacy and safety of interventional...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
DEB-TACE, Lenvatinib and Anti-PD(L)1 Antibody as Conversion Therapy for Intrahepatic Cholangiocarcinoma N/A The aim of this study is to the efficacy, prognosis, adverse effects, and f...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial